ArticleInfectious diseases and therapy2022

A Randomized Controlled Trial to Evaluate the Safety and Efficacy of a Novel Inhaled Biologic Therapeutic in Adults with Respiratory Distress Secondary to COVID-19 Infection.

Michael Roshon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.